LLY stock – State Reviewer

Finance

Analyst’s Sets Eli Lilly and Company (NYSE:LLY) New Target at $216.36: LLY is Now On A Buy List

Eli Lilly and Company (NYSE:LLY) has a beta of 0.24, a 12-month trailing P/E ratio of 32.73, and a growth ratio of 2.56. The stock’s

Industry

Eli Lilly and Company (NYSE:LLY) moved up 15.98% in a month: Spotting A Buy Candidate

Eli Lilly and Company (NYSE:LLY) Relative Strength Index (RSI) is 70.27, with weekly volatility at 2.94% and ATR at 6.27. The LLY stock’s 52-week price

Industry

Are Eli Lilly and Company (NYSE:LLY) Prospects Worsening?

Eli Lilly and Company (NYSE:LLY) has a beta of 0.25, a 12-month trailing P/E ratio of 30.26, and a growth ratio of 2.39. The stock’s

Industry

Eli Lilly and Company (LLY) Gain 18.30% YTD: Chances Are, Buyers Will Win the Tug-of-War

Eli Lilly and Company (NYSE:LLY) Relative Strength Index (RSI) is 62.17, with weekly volatility at 2.03% and ATR at 3.75. The LLY stock’s 52-week price

Stock Earnings

Eli Lilly (LLY), Pfizer (PFE), BioNTech (BNTX), Citigroup (C), NIO Stood In Green on Monday

On Monday, Eli Lilly and Company (LLY) was up +11.74% to $185.94. Company’s Donanemab, an experimental antibody targeting a transformed type of beta-amyloid called N3pG,

Tag: LLY stock

Analyst’s Sets Eli Lilly and Company (NYSE:LLY) New Target at $216.36: LLY is Now On A Buy List

Eli Lilly and Company (NYSE:LLY) moved up 15.98% in a month: Spotting A Buy Candidate

Are Eli Lilly and Company (NYSE:LLY) Prospects Worsening?

Eli Lilly and Company (LLY) Gain 18.30% YTD: Chances Are, Buyers Will Win the Tug-of-War

Eli Lilly (LLY), Pfizer (PFE), BioNTech (BNTX), Citigroup (C), NIO Stood In Green on Monday

Quick Links

Categories